OmniaBio
Abhishek Dhawan, PhD is a Lead Scientist III at OmniaBio with extensive experience in stem cell biology and cancer research. Previously, Abhishek worked as a Postdoctoral Research Fellow at Moffitt Cancer Center, focusing on investigating CD34+ hematopoietic stem and progenitor cells in Chronic Myelomonocytic Leukemia. Abhishek also held research positions at Columbia University Medical Center, University Clinic Carl Gustav Carus, and Dresden International Graduate School for Biomedicine and Bioengineering. Abhishek's educational background includes a Ph.D. in Stem Cell Biology from Dresden International Graduate School for Biomedicine and Bioengineering.
This person is not in any teams
OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.